Modeling, design and synthesis of new heteroaryl ethylenes active against the MCF-7 breast cancer cell-line

被引：28

作者：

Barresi, Vincenza ^{[1
]}

Bonaccorso, Carmela ^{[2
]}

Consiglio, Giuseppe ^{[3
]}

Goracci, Laura ^{[2
]}

Musso, Nicolo ^{[1
]}

Musumarra, Giuseppe ^{[2
]}

Satriano, Cristina ^{[2
]}

Fortuna, Cosimo G. ^{[2
]}

机构：

[1] Univ Catania, Dipartimento Sci Biomed, Sez Biochim, I-95125 Catania, Italy

[2] Univ Catania, Dipartimento Sci Chim, I-95125 Catania, Italy

[3] Univ Catania, Dipartimento Ingn Ind & Meccan, I-95125 Catania, Italy

来源：

MOLECULAR BIOSYSTEMS | 2013年 / 9卷 / 10期

关键词：

VITRO ANTITUMOR-ACTIVITY; IN-SILICO DISCOVERY; QSAR MODEL; CHEMOTHERAPY; AGENTS; TRANS; DRUG; ANTAGONISTS; BIOMARKERS; CHEMISTRY;

D O I：

10.1039/c3mb70151d

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A dataset of 50 compounds was used to generate a QSAR model and to design 9 new heteroaryl ethylenes. These compounds were synthesized, tested in vitro and a significant agreement with in silico predictions observed. Studies using Laser Scanning Confocal Microscopy pointed out that the compounds may act by different mechanisms.

引用

收藏

页码：2426 / 2429

页数：4

相关论文

共 30 条

[1] Naive Bayes QSDR classification based on spiral-graph Shannon entropies for protein biomarkers in human colon cancer [J].

Aguiar-Pulido, Vanessa ;

Munteanu, Cristian R. ;

Seoane, Jose A. ;

Fernandez-Blanco, Enrique ;

Perez-Montoto, Lazaro G. ;

Gonzalez-Diaz, Humberto ;

Dorado, Julian .

MOLECULAR BIOSYSTEMS, 2012, 8 (06) :1716-1722

[2] New small-molecule tubulin inhibitors [J].

Bacher, G ;

Beckers, T ;

Emig, P ;

Klenner, T ;

Kutscher, B ;

Nickel, B .

PURE AND APPLIED CHEMISTRY, 2001, 73 (09) :1459-1464

[3] Design, synthesis and in vitro antitumor activity of new trans 2-[2-(heteroaryl)vinyl]-1,3-dimethylimidazolium iodides [J].

Ballistreri, FP ;

Barresi, V ;

Benedetti, P ;

Caltabiano, G ;

Fortuna, CG ;

Longo, ML ;

Musumarra, G .

BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (07) :1689-1695

[4] Synthesis, spectroscopic characterization and in vitro antitumor activity of new trans 1-heteroaryl-2-(1-methylpyridinium-2-yl) ethylenes [J].

Ballistreri, FP ;

Barresi, V ;

Consiglio, G ;

Fortuna, CG ;

Longo, ML ;

Musumarra, G .

ARKIVOC, 2003, :105-117

[5] In vitro antitumor activities of 2,6-di-[2-(Heteroaryl)vinyllpyridines and pyridiniums [J].

Barresi, V ;

Condorelli, DF ;

Fortuna, CG ;

Musumarra, G ;

Scirè, S .

BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (09) :2899-2904

[6] Small molecule antagonists of the MDM2 oncoprotein as anticancer agents [J].

Buolamwini, JK ;

Addo, J ;

Kamath, S ;

Patil, S ;

Mason, D ;

Ores, M .

CURRENT CANCER DRUG TARGETS, 2005, 5 (01) :57-68

[7] Targeted cancer therapy: Conferring specificity to cytotoxic drugs [J].

Chari, Ravi V. J. .

ACCOUNTS OF CHEMICAL RESEARCH, 2008, 41 (01) :98-107

[8]

Cozzi Paolo, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P93, DOI 10.2174/1568011043482061

[9] Predicting blood-brain barrier permeation from three-dimensional molecular structure [J].

Crivori, P ;

Cruciani, G ;

Carrupt, PA ;

Testa, B .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (11) :2204-2216

[10] Molecular fields in quantitative structure-permeation relationships: the VolSurf approach [J].

Cruciani, C ;

Crivori, P ;

Carrupt, PA ;

Testa, B .

JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2000, 503 (1-2) :17-30